冠心病患者个体化抗血小板治疗有效性和安全性的系统评价

冠心病患者个体化抗血小板治疗有效性和安全性的系统评价(5)

http://www.100md.com 2019年2月1日《中国药房》 20193

[ 9 ] VALGIMIGLI M，CAMPO G，DE CESARE N，et al. Intensifying platelet inhibition with tirofiban in poor responders to aspirin，clopidogrel，or both agents undergoing elective coronary intervention：results from the double-blind，prospective，randomized tailoring treatment with tiro?ban in patients showing resistance to aspirin and/or resistance to clopidogrel study[J]. Circulation ......

上一页第 1 2 3 4 5 6 页下一页

百拇医药网 http://www.100md.com/html/paper/1001-0408/2019/03/23-4.htm

您现在查看是摘要页，全文长 2609 字符。